MicroPort Orthopedics Inc.
MicroPort Orthopedics Inc.
Explore linked clinical trials.19 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NitrX Total Knee Arthroplasty RSA | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Active, not recruiting | Not applicable | 2026-09-22 | NCT05151315 | |
| Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthropathy, avascular necrosis, bone disorder, musculoskeletal system disorder, osteonecrosis | Active, not recruiting | Not stated | 2026-02-06 | NCT07391592 | |
| l Investigation of Robotic-assisted TKA (RA-TKA) With Skywalker and Evolution Medial Pivot Knee (eMP Knee) | Arthroplasty Complications; Knee Arthropathy; Robotic Assisted Arthroplasty; TKA Outcomes | Recruiting | Not applicable | 2025-05-13 | NCT06969222 | |
| Comparison of Image Based Robotic Total Knee Arthroplasty vs Imageless Augmented Reality Assisted Total Knee Arthroplasty | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Recruiting | Not applicable | 2025-03-24 | NCT06891807 | |
| Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot Versus Single Radius Design for Total Knee Arthroplasty | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Recruiting | Not applicable | 2025-01-22 | NCT04814082 | |
| Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, avascular necrosis, bone disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder | Enrolling by invitation | Not stated | 2024-03-20 | NCT04816773 | |
| Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, avascular necrosis, bone disorder, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, osteonecrosis, rheumatic disorder | Active, not recruiting | Not stated | 2024-03-20 | NCT04301622 | |
| Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral Stem | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ankylosis, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder | Enrolling by invitation | Not stated | 2024-03-20 | NCT04147559 | |
| Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Enrolling by invitation | Not stated | 2024-03-20 | NCT04145401 | |
| EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Recruiting | Not stated | 2024-01-22 | NCT06142669 | |
| Post Market Clinical Follow-Up Study Protocol for PROFEMUR® TL Modular Femoral Stems | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not stated | 2023-11-18 | NCT02239783 | |
| Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Z Revision Femoral Stems | arthropathy, musculoskeletal system disorder | Enrolling by invitation | Not stated | 2023-11-14 | NCT04064008 | |
| Post Market Clinical Follow-Up Study Protocol for PROCOTYL® C Acetabular Components | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Enrolling by invitation | Not stated | 2023-11-14 | NCT03576573 | |
| Post Market Clinical Follow-Up Study Protocol for CONSERVE® Press-Fit Femoral Components | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not stated | 2023-06-07 | NCT02285842 | |
| Post Market Clinical Follow-up Study Protocol for DYNASTY® BioFoam® Acetabular Components | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not stated | 2023-06-07 | NCT02149667 | |
| Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Preserve Femoral Stem | arthropathy, musculoskeletal system disorder | Active, not recruiting | Not stated | 2023-04-28 | NCT03865667 | |
| Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts | Skin and Connective Tissue Diseases, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not stated | 2022-10-13 | NCT02351414 | |
| Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not stated | 2022-10-13 | NCT02314702 | |
| PMCF Study Protocol for PROFEMUR® Gladiator Plasma Femoral Stems and PROCOTYL® L Beaded Acetabular Components | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not stated | 2022-07-08 | NCT02823834 |